Casi Pharmaceuticals inc   (CASI)
Other Ticker:  


Casi Pharmaceuticals inc

CASI's Financial Statements and Analysis

Casi Pharmaceuticals inc increased forth quarter of 2022 net loss per share of $-3.01 compare to net loss per share of $-0.04 recorded in the same quarter a year ago a decrease compare to $0.00 realized in previous quarter.

forth quarter of 2022
Earnings Per Share Revenues
$ -3.01 $  43 Mill
$-2.97     $+34M     +370.7 %

Casi Pharmaceuticals Inc 's Revenue rose by 370.7 % in forth quarter of 2022 (Dec 31 2022) year on year, to $43 million and advanced by sequentially.

Casi Pharmaceuticals Inc is Expected to report next financial results on November 13, 2023.

More on CASI's Income Statement

Casi Pharmaceuticals Inc 's in theforth quarter of 2022 recorded net loss of $-40.257 million, an increase from net loss of $-5.395 million in IV. Quarter a year ago.

Sequentially company realized a net loss, compared to net income of $0.000 million in the previous quarter.

More on CASI's Growth

Casi Pharmaceuticals Inc Inventories
Inventories grew by 221.87 % to $6 million from IV. Quarter a year ago, sequentially inventories fell by 0 %. CASI's Cash flow In theforth quarter of 2022 company's net cash flow was $8 million, capital expenditures fell by 7.61%, to $-6 millions compare to same quarter a year ago and fell by